Development and validation of a novel stem cell subtype for bladder cancer based on stem genomic profiling

Bladder cancer (BLCA) is the fifth most common type of cancer worldwide, with high recurrence and progression rates. Although considerable progress has been made in the treatment of BLCA through accurate typin...

Source: Stem Cell Research and Therapy - October 28, 2020 Category: Stem Cells Authors: Chaozhi Tang, Jiakang Ma, Xiuli Liu and Zhengchun Liu Tags: Research Source Type: research